SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-02-004588
Filing Date
2002-10-24
Accepted
2002-10-24 15:00:18
Documents
7
Period of Report
2002-09-30

Document Format Files

Seq Description Document Type Size
1 HYBRIDON, INC. b44464hie10vq.htm 10-Q 318566
3 EX-10.1 EXECUTIVE STOCK OPTION AGMNT - 1,260,000 b44464hiexv10w1.txt EX-10.1 26381
4 EX-10.2 EXECUTIVE STOCK OPTION AGMNT - 550,000 b44464hiexv10w2.txt EX-10.2 22106
5 EX-10.3 EXECUTIVE STOCK OPTION AGMNT - 500,000 b44464hiexv10w3.txt EX-10.3 25680
6 EX-10.4 CONSULTING AGREEMENT DATED OCTOBER 1, 2002 b44464hiexv10w4.txt EX-10.4 19083
7 EX-99.1 CERTIFICATIONS PURSUANT TO SECTION 906 b44464hiexv99w1.txt EX-99.1 2245
8 COURTESY PDF COPY b44464hie10vqxpdfy.pdf 10-Q 472121
  Complete submission text file 0000950135-02-004588.txt   888559
Mailing Address 345 VASSAR STREET CAMBRIDGE MA 02139
Business Address 345 VASSAR STREET CAMBRIDGE MA 02139 6176795500
HYBRIDON INC (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27352 | Film No.: 02797262
SIC: 2836 Biological Products, (No Diagnostic Substances)